Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Keratosis, Actinic 5Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 2Neoplasm Metastasis 2Liver Neoplasms 2Colorectal Neoplasms 2Tongue Neoplasms 1Precancerous Conditions 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neurofibromatosis 1 1Neurofibroma 1Mesothelioma, Malignant 1Mesothelioma 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Leukoplakia, Oral 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1Epitheliod Malignant Pleural Mesothelioma 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Barrett Esophagus 1

Interventions

mirdametinib 2tipifarnib 1peginterferon alfa-2b 1binimetinib 1antineoplaston AS 2-1 1antineoplaston A10 1Vincristine 1Temozolomide 1Photochemotherapy 1Mn-PyC3A 1Everolimus 1Celecoxib 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neurofibroma × Photochemotherapy × Clear all
NCT02728388 2025-05-08

Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II

Medical College of Wisconsin

Phase 2 Recruiting
30 enrolled
CNS

Neurofibroma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡